ArticleActa neurologica Belgica2025
Cerebrospinal fluid biomarkers of efficacy in patients affected by spinal muscular atrophy type 1 treated with nusinersen.
Maria Sframeli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it